• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: FARAPULSE, INC. FARADRIVE STEERABLE SHEATH CLEAR; CARDIAC IRREVERSIBLE ELECTROPORATION SYSTEM CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

FARAPULSE, INC. FARADRIVE STEERABLE SHEATH CLEAR; CARDIAC IRREVERSIBLE ELECTROPORATION SYSTEM CATHETER Back to Search Results
Lot Number CL11904
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Pain (1994)
Event Date 12/06/2023
Event Type  Injury  
Manufacturer Narrative
The device has not been received for analysis.Upon receipt and completion of the failure analysis of the complaint device, if there is any further relevant information from that review, a supplemental medwatch will be filed.
 
Event Description
Faradise clinical study pf114 subject id: (b)(6).An index ablation procedure was completed on 28aug2024.Following a repeat pulse field ablation (pfa) procedure with a farawave catheter was performed on (b)(6) 2024.The following day, the patient experienced low back pain and was diagnoses by the general practitioner with a lumbago.As treatment celecoxib 200 mg and paracetamol were prescribed.The case is now reported as resolved.The related devices to the procedure will not be returned.
 
Manufacturer Narrative
Based upon analysis of all available information, bsc's investigation found no evidence to indicate that the pain was related to product performance of the faradrive sheath.There was no report of any device performance concerns.Investigators examined the details provided in the event description and found that the patient was diagnosed with lumbago.Therefore, it was determined that the most likely cause of the chest pain was an adverse event related to patient condition.
 
Event Description
Faradise clinical study (b)(6) subject id: (b)(6).An index ablation procedure was completed on (b)(6) 2024.Following a repeat pulse field ablation (pfa) procedure with a farawave catheter was performed on (b)(6) 2024.The following day, the patient experienced low back pain and was diagnoses by the general practitioner with a lumbago.As treatment celecoxib 200 mg and paracetamol were prescribed.The case is now reported as resolved.The related devices to the procedure will not be returned.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FARADRIVE STEERABLE SHEATH CLEAR
Type of Device
CARDIAC IRREVERSIBLE ELECTROPORATION SYSTEM CATHETER
Manufacturer (Section D)
FARAPULSE, INC.
3715 haven avenue
suite 110
menlo park CA 94025
Manufacturer (Section G)
CENTERPOINT SYSTEMS
3338 parkway blvd
west valley city UT 84119
Manufacturer Contact
angela hinkley
4100 hamline avenue north
dc a330
saint paul, MN 55112
6514400979
MDR Report Key18859658
MDR Text Key337184071
Report Number2124215-2024-14112
Device Sequence Number1
Product Code QZI
Combination Product (y/n)N
Reporter Country CodeBE
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Study
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 08/14/2024
2 Devices were Involved in the Event: 1   2  
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Lot NumberCL11904
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 02/28/2024
Initial Date FDA Received03/07/2024
Supplement Dates Manufacturer Received07/30/2024
Supplement Dates FDA Received08/14/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured04/17/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age72 YR
Patient SexFemale
Patient Weight67 KG
-
-